Interim Division Chief
Surgical Director, ºÚÁÏÍø Lung Transplant Program
Director, Cardiothoracic Surgery Residency Program
Professor of Surgery and Anesthesiology
Clinical Interests
Thoracic oncology including cancer of lung and esophagus, heart and lung transplantation, minimally invasive thoracic surgery, lung and esophageal surgery, cardiac surgery including ventricular assist device (VAD) implantation.
Research Interests
Lung cancer (CALGB trial of lobectomy versus sublobar resection for small (<2cm) peripheral non-small cell lung cancer); use of lungs from non-heart-beating donors for transplantation.
Education
- Cardiothoracic Surgery Residency, University of North Carolina at Chapel Hill, Chapel Hill, NC
- Surgical Research Fellowship, Cardiovascular Lab, Henry Ford Hospital, Detroit, MI,
- General Surgery Residency, Henry Ford Hospital, Detroit, MI
- MD, Michigan State University, East Lansing, MI
- Post-Baccalaureate Premedical Program, University of Michigan, Ann Arbor, MI
- BS, Chemistry, University of Michigan, Ann Arbor, MI
Recent Publications
View Dr. Haithcock’s recent research publications onÌý.
Patient Stories
| Double Lung Transplant During COVID-19 | January 5, 2022
Ìý |
| Linda Kelly Finds Hope and Care During COVID-19 | January 21, 2021
|
On May 29, Tolisha woke up with difficulty breathing, unable to even walk to the bathroom. Her husband called an ambulance. On August 10, Tolisha Alexander was the first ºÚÁÏÍø patient to undergo a lung transplant due to COVID-19. 
Linda Kelly was diagnosed with breast cancer 20 years ago and received treatment that included a mastectomy and radiation. The medical intervention saved her life but led to some later complications that forced her to seek care in mid-2020. 